We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 134

Final rules: essential health benefits, cost-sharing, and actuarial value

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • May 31 2013

Beginning in 2014, non-grandfathered individual health insurance policies and policies issued to small employers must provide "essential health

Decree on advertising medical devices in France

  • Hodgson Russ LLP
  • -
  • France
  • -
  • August 27 2012

A new French law wants to strengthen the safety of drugs and medical products

New French Sunshine Act guidance

  • Hodgson Russ LLP
  • -
  • France, USA
  • -
  • July 11 2013

On June 12, 2013, the French Ministry of Health published Circulaire No. DGSPF22013224 relative to Article 2 of the Law No. 2011-2012 of December

FDA issues draft guidance on medical device reporting for manufacturers

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • September 3 2013

On July 9, 2013, the FDA issued a draft guidance document titled "Medical Device Reporting for Manufacturers." Written in a question and answer

Clinical trial financial disclosure: French legislation

  • Hodgson Russ LLP
  • -
  • France
  • -
  • September 6 2011

The European Parliament and Council’s Directive 200120EC dated April 4, 2001, which has been modified several times, is related to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use

The application of the medical device excise tax to foreign manufacturers selling to end-users in the United States

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • May 6 2013

As of January 1, 2013, the first sale of a taxable medical device in the United States by a manufacturer, producer, or importer has been subject to a

Medical devices offer fertile ground for future whistleblower activity

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • May 29 2014

Recent gatherings of False Claims Act attorneys who represent whistleblowers, the government, and the defense revealed a consensus

No relief in sight for health-care providers

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • November 22 2010

In recent years, New York health-care providers have seen an explosion of state oversight and enforcement activities

Can personal injury lawyers be liable to medical plans?

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • October 31 2013

The U.S. District Court for the Eastern District of New York recently held that a medical plan can enforce a lien against attorneys' fees received in

HHS proposes substantial reinsurance fee

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • February 28 2013

The Patient Protection and Affordable Care Act (PPACA) establishes, among other things, a transitional reinsurance program to provide payments to